Alterations or dysregulation of the EGF gene or its signaling pathway can be associated with various diseases, including cancers viz. colorectal cancer, non-small cell lung cancer (NSCLC), prostate and pancreatic cancers. The gene discussed is EGF; the disease is non-small cell lung carcinoma.